Skip to main content
Pulike Biological Engineering,Inc. logo

Pulike Biological Engineering,Inc. — Investor Relations & Filings

Ticker · 603566 ISIN · CNE1000025N0 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 1,080 across all filing types
Latest filing 2016-10-18 Capital/Financing Update
Country CN China
Listing Shanghai Stock Exchange 603566

About Pulike Biological Engineering,Inc.

http://en.pulike.com.cn/

Pulike Biological Engineering, Inc. specializes in the research, development, and production of veterinary biological products and pharmaceutical preparations. The company focuses on animal disease prevention through the manufacture of high-end vaccines, diagnostic reagents, and veterinary medicines. Its product range primarily serves the swine and poultry sectors, featuring advanced biologicals such as genetically engineered vaccines and synthetic peptide products. Pulike maintains a strong emphasis on technological innovation, utilizing national-level research platforms to develop solutions for complex animal health challenges. The company’s core activities encompass the entire value chain from basic biotechnology research to the commercialization of veterinary health solutions, aiming to improve livestock productivity and biosecurity.

Recent filings

Filing Released Lang Actions
关于筹划股权激励事项复牌的公告
Capital/Financing Update Classification · 95% confidence The document is a short announcement regarding the resumption of trading (复牌) of the company's stock following the planning of an equity incentive (股权激励) matter. It mentions the board's approval of a restricted stock incentive plan and the application to the stock exchange for resumption. The document is brief (438 characters) and serves as a notification rather than a detailed report or financial statement. It does not contain financial data, audit information, or detailed management discussion. It is an announcement related to capital/financing activities (equity incentive plan) and stock trading status. Therefore, the most appropriate classification is Capital/Financing Update (CAP).
2016-10-18 Chinese
关于2016年限制性股票激励计划草案摘要的公告
Share Issue/Capital Change Classification · 95% confidence The document is a detailed announcement regarding a 2016 restricted stock incentive plan draft by 普莱柯生物工程股份有限公司. It includes comprehensive information about the stock incentive plan, including the number of shares, pricing, vesting conditions, performance targets, rights and obligations of the company and incentive recipients, adjustment methods, and procedures for implementation and termination. The document is lengthy (15,000 characters) and contains substantive content about the stock incentive plan rather than just an announcement of a report or a brief summary. It is not a financial report like an annual or interim report, nor is it a call transcript or legal proceeding. It is a corporate announcement about a capital change related to share issuance for employee incentives. Therefore, the most appropriate classification is Share Issue/Capital Change (SHA).
2016-10-18 Chinese
限制性股票激励计划（草案）
Board/Management Information Classification · 95% confidence The document is a detailed draft of a restricted stock incentive plan for a company, including legal references, stock allocation, conditions for granting and lifting restrictions, accounting treatment, and implementation procedures. It is not a financial report, earnings release, or regulatory announcement but a comprehensive management and governance document related to stock-based compensation for executives and key employees. This fits the category of Board/Management Information (MANG), as it involves management incentives and governance of stock awards. The document length and detail confirm it is the plan itself, not just an announcement or summary.
2016-10-18 Chinese
2016年限制性股票激励计划激励对象名单
Remuneration Information Classification · 95% confidence The document is titled as a list of incentive recipients under a 2016 restricted stock incentive plan for a company. It lists names, positions, and stock quantities granted to directors, senior management, and other employees. There is no financial data, no discussion of financial results, no regulatory certifications, or announcements of report publications. The content is focused on stock incentive allocations to management and employees, which is related to remuneration or compensation information. Given the detailed listing of stock incentives to executives and employees, this fits best under Remuneration Information (DEF 14A) category, which covers reports detailing compensation for top executives and directors. The document length is short (2400 characters), and it is not an announcement of a report but the actual list of incentive recipients. Therefore, the classification is DEF 14A with high confidence.
2016-10-18 Chinese
北京德恒律师事务所关于公司限制性股票激励计划（草案）的法律意见
Capital/Financing Update Classification · 95% confidence The document is a detailed legal opinion from a law firm regarding a company's restricted stock incentive plan (股权激励计划). It discusses the legal compliance, procedures, stock quantities, pricing, vesting conditions, and other regulatory aspects of the stock incentive plan. The document is not a financial report, earnings release, or management discussion, but a legal opinion related to a capital/financing activity involving issuance of restricted shares as part of an employee incentive plan. This fits best under Capital/Financing Update (CAP) as it relates to company fundraising and capital structure changes through stock incentives. The document length is substantial and contains detailed legal and procedural content, not just an announcement or certification, so it is not RPA or RNS. Therefore, the classification is CAP with high confidence.
2016-10-18 Chinese
关于召开2016年第一次临时股东大会的通知
AGM Information Classification · 95% confidence The document is a notice about convening the 2016 first extraordinary general meeting of shareholders (临时股东大会) for 普莱柯生物工程股份有限公司. It details the meeting date, voting methods, agenda items, and procedural instructions for shareholders. It does not contain financial statements or results but is an announcement related to a shareholders meeting. The document length is 3311 characters, which is relatively short and consistent with a meeting notice rather than a full report. Therefore, this document fits the category of AGM Information (AGM-R), which covers presentations and materials shared during the Annual General Meeting or similar shareholder meetings.
2016-10-18 Chinese

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.